Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details Narrative)

v3.19.1
NON CONTROLLING INTEREST (Details Narrative) - USD ($)
Mar. 31, 2019
Jul. 28, 2016
BioCorRx Pharmaceuticals, Inc [Member]    
Ownership percentage hold by former officers   24.20%
Ownership percentage hold by company   75.80%
BioCorRx Pharmaceuticals, Inc [Member]    
Licensing rights, carrying value $ 250,000